- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/114 - Fusobacterium
Patent holdings for IPC class A61K 39/114
Total number of patents in this class: 43
10-year publication summary
|
2
|
5
|
5
|
2
|
3
|
0
|
5
|
4
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cornell University | 3455 |
5 |
| Kansas State University Research Foundation | 483 |
4 |
| Keio University | 1153 |
4 |
| The University of Tokyo | 4390 |
4 |
| Vaxxinova US, Inc. | 35 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3303 |
3 |
| Universite Paul Sabatier Toulouse III | 478 |
3 |
| The Regents of the University of California | 20902 |
2 |
| Centre hospitalier universitaire de Toulouse | 182 |
2 |
| Provincial Health Services Authority | 201 |
2 |
| University of Saskatchewan | 489 |
2 |
| Glaxosmithkline Biologicals S.A. | 1602 |
1 |
| British Columbia Cancer Agency Branch | 178 |
1 |
| Centre hospitalier universitaire de Montpellier | 143 |
1 |
| Epitopix, LLC | 8 |
1 |
| Qu Biologics | 1 |
1 |
| Relica Genomics Inc. | 3 |
1 |
| Fred Hutchinson Cancer Center | 484 |
1 |
| Sentinel Environmental Group, LLC | 1 |
1 |
| Other owners | 0 |